Control of Streptococcus pneumoniae colonisation at human mucosal surfaces is critical to reducing 26 the burden of pneumonia and invasive pneumococcal disease, interrupting transmission, and 27 achieving herd protection. Using an Experimental Human Pneumococcal Carriage Model (EHPC), 28
INTRODUCTION 46 47
Colonisation of upper respiratory tract (URT) mucosa by a range of pathogenic bacteria is a 48 necessary precursor to both disease and onward transmission. Although Streptococcus pneumoniae 49 is a common coloniser of the human nasopharynx, it is estimated to be responsible for >500,000 50 deaths due to pneumonia, meningitis and sepsis in children under five years of age worldwide 1 . 51
52
In Europe and North America, there has been a dramatic effect of pneumococcal conjugate vaccine 53 (PCV) on vaccine serotype (VT) invasive disease, carriage and transmission 2 . However, the 54 emergence of non-VT pneumococcal disease worldwide and the more modest impact of PCV on 55 colonisation in high transmission settings, threaten this success 3 . Control of pneumococcal URT 56 colonisation in humans is not fully understood 4 , and so defining the mechanistic basis for host control 57 of pneumococcal colonisation at the mucosal surface is therefore crucial for the further optimisation 58 of therapeutic interventions which target carriage and transmission. The process of transmission is 59 not fully understood, but mucosal inflammation, potentially enhanced by co-infection with viruses 60 such as Influenza A, has been proposed to mediate bacterial shedding from the nasopharynx 5 . 61 62 Naturally acquired immunity to S. pneumoniae proteins are primarily mediated by mucosal T cells 63 and anti-protein antibodies, controlled by Treg 6-8 . The role of anti-capsule polysaccharide antibodies 64 in naturally acquired immune control remains unresolved 9 . URT epithelium is central to this 65 immunity 10 , binding and transporting antibodies, sensing bacteria via a range of surface and 66 intracellular pathogen-associated molecular patterns (PAMPs) receptors, and rapidly transducing 67 signals to recruit innate and inflammatory immune mechanisms 11, 12 . 68 69 Murine models suggest that adherence of S. pneumoniae to the mucosal epithelium may be followed 70 by paracellular transmigration and tight junction modulation 13, 14 . In contrast, studies of immortalised 71 epithelial cell monolayers implicate endocytosis of S. pneumoniae, mediated though pneumococcal 72 protein C-polymeric immunoglobulin receptor interactions 15, 16 . The relative importance of epithelial 73 endocytosis and paracellular migration in colonisation and invasion remains uncertain 16 , but could 74 influence epithelial sensing of this otherwise extracellular pathogen 14 . For example this may include 75 Nod1 signalling via peptidoglycan 17 and TLR4 signalling via pneumolysin, a pore-forming toxin that 76 induces inflammation and mediates both clearance and transmission in an infant mouse model [18] [19] [20] . 77
78
We have explored the hypothesis that pneumococcal-epithelial engagement dictates the 79 inflammatory/ innate immune response and therefore the outcome of colonisation. Much of what we 80 understand of the control of pneumococcal colonisation is derived from epidemiological studies and 81 murine carriage models. The Experimental Human Pneumococcal Carriage (EHPC) model provides 82 a well-controlled, reproducible tool to characterise the cellular and molecular mechanisms that 83 underlie pneumococcal colonisation in humans 21 . The model has revealed that pneumococcal 84 carriage results in neutrophil degranulation and monocyte recruitment to the nasopharynx 22 , 85
protecting against re-challenge with the same strain for up to one year 21, 23 . 86
87
We have used human epithelial cell lines and different strains of S. pneumoniae to further probe 88 these mechanisms and derive an epithelial transcriptome module to interrogate the host response 89 in the EHPC model. We show that pneumococcal colonisation in humans is characterised by micro-90 colony formation, junctional protein association and migration across the epithelial barrier without 91 disease, which we have termed micro-invasion. This pattern of bacterial-host cell association shapes 92 epithelial sensing of S. pneumoniae, which is partially pneumolysin dependent. Together, our data 93 suggest that pneumococcal engagement with the epithelium in the early phases of colonisation may 94 occur without eliciting a marked host response, but as colonisation becomes more established, 95 epithelial sensing of S. pneumoniae enhances innate immunity/ inflammation which we propose 96 promotes clearance. To determine whether pneumococcal colonisation leads to epithelial activation, we analysed nasal 142 curette biopsy cells for surface expression of molecules expressed in airway epithelium which have 143 previously been shown to be upregulated in response to common bacterial stimuli and are involved 144 in immune cell recruitment. These were EpCAM (for epithelial cell identification), IL-22Ra1, HLADR, 145 CD40, CD54 and CD107a ( Supplementary Figure 2a-d ). We did not detect a significant change in 146 the relative expression of IL-22Ra1 (protects the epithelial barrier, promotes anti-microbial product 147 secretion during infection, modulating pneumococcal carriage and clearance 24 ), HLADR (mediates 148 T cell-antigen recognition and is a marker of epithelial activation 25 ), CD40 (co-stimulatory protein 149 which binds CD154 26 ( Supplementary Figure 2e -g)), or CD54 (a leukocyte adhesion molecule which 150 is also upregulated by CD40 26,27 , initiating neutrophil migration and recruitment 28 , Figure 2a ). 151
However, although numbers of epithelial cells expressing CD107a did not change over time ( Figure  152 2b, left), we observed an increase in CD107a high expression at day 2 post inoculation in carriage 153 positive volunteers vs. carriage negative volunteers (Figure 2b , right). CD107a in the epithelium 154 forms the membrane glycoprotein of late endosomes and phagolysosomes 16 and has previously 155 been implicated in pneumococcal endocytosis 16 . These data highlight the ability of the 156 pneumococcus to colonise the nasopharynx without marked inflammation and potentially implicate 157 CD107a in the process. 158 159 S. pneumoniae infection of nasopharyngeal epithelial cells in vitro is associated with 160 pneumococcal adhesion, micro-colony formation and micro-invasion 161
To further understand epithelial responses to S. pneumoniae observed in the EHPC model, we 162 undertook infection experiments with Detroit 562 epithelial cells. We compared the 6B response with 163 two other representative clinical isolates; a 23F strain, TIGR4 (the original sequenced strain 29 ) and 164 a TIGR4 pneumolysin deletion mutant strain (dPly). 165 166 TIGR4 association with Detroit 562 cells was over 100-fold higher for adhesion and over 70-fold 167 higher for invasion after three hours infection, compared to 6B or 23F strains (Figure 3a Transmigration across the epithelium (endocytosis or paracellular movement), as measured by the 181 culture of pneumococci from the basal chamber of transwell inserts, was most marked with 23F 182 (Figure 3c , five-fold higher compared to TIGR4, after three hours infection). A similar pattern of 183 epithelial interaction was also seen at one hour suggesting these observations are not simply 184 explained by differential growth. 185
186
Epithelial infection with the dPly-TIGR4 mutant showed a significant increase in adherence ( Figure  187 3a, ten-fold higher after three hours infection), internalisation (Figure 3b , three-fold higher after three 188 hours infection, Figure 3j ), but no significant differences in transmigration ( Figure 3c 
Endocytosis-related micro-invasion and transmigration 204
To confirm that the pneumococcal endocytosis leads to transmigration across the epithelium, 205 endocytosis was inhibited with dynasore and nystatin 16 . After one hour of infection, cellular uptake 206 of 23F was inhibited by 82% ( Figure 4a ) and transmigration across the cell monolayer by 85% ( Figure  207 4b). This inhibition of endocytosis and transmigration was also seen with TIGR4 (data not shown). 208
In agreement with previous studies using A549 and Calu3 cells 30 , we found that viable pneumococci 209
in Detroit 562 cells decreased over time ( Supplementary Figure 5a ). Using gentamicin treatment to 210 eliminate the original extracellular inoculum, we observed S. pneumoniae in the apical and basal 211 media ( Supplementary Figure 5b ), suggesting egress from the epithelium. To assess the inflammatory consequences of pneumococcal-epithelial infections in vitro, we 241 measured a cytokine panel in Detroit 562 cell supernatants following S. pneumoniae incubation 242 ( Figure 5c ). We detected a significant increase in IL-6 and IL-8, which were strain dependent and 243 partially pneumolysin dependent. In line with surface marker observations, only TIGR4 significantly 244 upregulated the secretion of soluble CD54, which was dependent on pneumolysin ( Figure 5c ). These 245 data highlight the less inflammatory nature of the 6B strain compared to the more invasive strain, 246 TIGR4, and the importance of pneumolysin in the epithelial response. Pneumococcal wild-type strain 247 differences were not explained by differences in pneumolysin activity, as determined by hemolysis 248 (Supplementary Figure 7) . 249 250
Innate transcriptomic responses to epithelial infection by S. pneumoniae in vitro 251
To explore the hypothesis that the pattern of epithelial adhesion and micro-invasion results in 252 differential epithelial responses, we performed RNAseq of Detroit 562 cells infected with our panel 253 of S. pneumoniae strains. In comparison to non-infected epithelial cell cultures, infection with TIGR4 254 upregulated expression of 1127 genes (517 unique genes), 23F upregulated 650 genes (69 unique 255 genes), and 6B upregulated 153 genes (10 unique genes), (Figure 6a ). The pneumolysin deficient 256 isogenic mutant of TIGR4 upregulated 220 genes (14 unique genes). Compared to non-infected 257 cells, 1193 genes were upregulated by S. pneumoniae infection overall and 93 were core to all 258 strains tested (differentially upregulated genes in Supplementary Excel file 1 and Reactome 259 pathways in Supplementary Excel file 2). 260
261
To elucidate the pathways that drive the transcriptional responses to each strain, we also undertook 262 transcription factor binding site enrichment analysis (Figure 6b , transcription factor binding site 263 enrichment analysis in Supplementary Excel file 3). The responses to 6B and pneumolysin deficient 264 strains were principally enriched in binding sites for the NFkB/Rel family of transcription factors, 265
indicating that an NFkB activation pathway was the dominant driver for responses to these strains. 266
In contrast, cellular responses to TIGR4 and 23F strains revealed enriched binding sites for more 267 diverse transcription factors, suggesting broader molecular pathways by which these strains may 268 influence cellular function. This analysis revealed particular enrichment of binding sites for beta-beta-269 alpha zinc finger superfamily of transcription factors, including KLF4, suggesting that these strains 270 upregulate mitogen activated protein kinase pathways upstream of these transcription factors 32 . 271
272
The sets of genes upregulated by each strain individually were subjected to core and interactome 273 Next, we sought to test whether these epithelial transcriptomic responses to S. pneumoniae were 287 also evident in the 6B EHPC model. We compared nasal transcriptomes sampled at two or nine days 288 after inoculation to pre-inoculation samples. These revealed enrichment of 162 transcripts among 289 individuals who became colonised (differential gene expression in Supplementary Excel file 4). 290
These genes included Claudin 5 and Claudin 17, Defensin β 103A/B, Cadherin 16, Desmocollin 1 291 and Gap junction protein α1, which suggests cytoskeletal re-organisation two days post-inoculation 292 in carriage positive individuals. By day 9 post-inoculation, molecules such as CCR3, matrix 293 metalloproteinase 12 and MHC II molecules were enriched, suggesting activation of the nasal 294 mucosa 34 . However, these genes were not significantly enriched for any immune response pathway 295 annotation perhaps because of the statistical stringency necessary for genome-wide multiple testing 296 and were not epithelial-specific. 297
298
Gene expression modules can successfully detect specific transcriptional programs in bulk tissue 35 . 299
Therefore, as an alternative approach, we sought to target specific epithelial responses in vivo using 300 the in vitro interactome. A direct comparison of transcripts for 6B revealed FOSL-1, an AP-1 301 transcription factor subunit, to be enriched with carriage, which has previously been reported to 302 become activated following pneumococcal challenge in BEAS-2B and HEK293 cells 36 . To expand 303 the sensitivity of the approach, we evaluated the expression of two transcriptional modules in the It is widely accepted that colonisation of the URT mucosa by many potentially pathogenic bacterial 318 species, involves transient association with the overlying mucus layer but that adherence to the 319 epithelial surface avoids mucus entrapment and muco-ciliary clearance 14,37 . While evading immunity, 320 bacterial replication then occurs prior to onward transmission to a new host. Even for S. pneumoniae, 321 the mechanisms underlying this transition from acquisition to established colonisation, and then 322 transmission and/or disease, are not well understood. By combining an EHPC model and in vitro 323 human cell culture systems, we show that pneumococcal colonisation leads to epithelial adherence, 324 micro-colony formation and migration across the epithelial barrier without disease, which we have 325 termed micro-invasion. The finding of co-association with junctional proteins provides a possible 326 mechanism for micro-invasion. Clearance of the pneumococcus from the mucosa in vivo occurs in 327 the context of micro-invasion. Indeed, epithelial micro-invasion and not bacterial load per se, appears 328 to dictate unique transcription factor binding site signatures, downstream cytokine, chemokine and 329 metabolic pathway enrichment ( Figure 8 ). 330
331
The concept of mucosal micro-invasion moves us away from current models of colonisation where 332 the pneumococcus is held up at the epithelial surface and that invasion leads to disease. Our data 333 are supported by murine colonisation experiments 38,39 and the detection of pneumococcal DNA in 334 blood of otherwise healthy, colonised children 40 . In line with other cell culture and murine 335 models 13,16,38,41 , we have demonstrated that pneumococcal micro-invasion occurs by endocytosis 336 through the formation of cytoplasmic vacuoles, and by paracellular transcytosis across the 337 epithelium. This process appears to be association with the formation of epithelial folds different from 338 the membrane ruffles previously reported with conventionally intracellular pathogens such as 339
Salmonella typhimurium 42 . Our study emphasises the active nature of these processes without 340 marked cellular damage or loss of barrier function. Micro-invasion of the epithelium may overcome 341 the inaccessibility of PAMP receptors located either at the epithelial basolateral surface or 342 intracellularly 43,44 . We have found that at early time points, micro-invasion in vitro is also 343 characterised by pneumococcal co-association with JAM-A and β catenin without evidence of barrier 344 dysfunction. In murine models at later time points, TLR-dependent Claudin 7 and Claudin 10 down-345 regulation enhanced pneumococcal translocation across the epithelium has been observed 13 . While 346 this may occur as inflammation becomes more prominent, our data suggest that micro-invasion can 347 happen without barrier disruption and that the epithelium plays an active role in the regulation of 348 these complex host-pathogen interactions 12 . How micro-invasion relates to the risk of invasive 349 pneumococcal disease remains to be determined but as demonstrated by the EHPC model, micro-350 invasion may occur in healthy individuals without symptoms. 351
352
The differential impact of micro-invasion on the epithelial transcriptomic response was striking with 353 considerable enrichment of multiple diverse transcription factors and signalling pathways related to 354 innate immunity with the most invasive pneumococcal strains. The interactome module highlights 355 that although enrichment of gene activation in response to all pneumococcal strains is apparent (the 356 core module), a more diverse range of epithelial gene activation occurs between strains, reflecting 357 specific host-pathogen interactions. Nasal colonisation in murine models is proinflammatory 45,46 , but 358 our in vitro and EHPC experiments with serotype 6B suggests this is not always the case, whereby 359 pneumococcal-host cell adherence, growth, endocytosis and paracellular migration can be 360 established without a marked host response. In the EHPC, clearance occurred around the time the 361 epithelial transcriptomic response was most prominent. Weiser and colleagues argue that the 362 colonising pneumococcus induces a host inflammatory response that mediates clearance, but also 363 promotes nutrient acquisition, mucus production and onward transmission 14,18,47 , which is supported 364 by murine models 48 and epidemiological studies of viral-coinfection 49 . It has been suggested that 365 pneumolysin induces neutrophil influx and degranulation, leading to increased secretions from the 366 nasopharynx, so promoting transmission 5,18 . We therefore suggest that the epithelial innate response 367 resulting from pneumococcal colonisation could promote both clearance and transmission. 368
369
The enrichment of binding sites for the transcription factor KLF4 transcription factors seen in our in 370 vitro data suggests a counter-regulatory process aimed at minimising inflammation. KLF4 plays a 371 role in barrier function, suppression of NFκB-dependent IL-8 secretion, regulation of IL-10 expression 372 via TLR9-MyD88 and Yes-1, in response to S. pneumoniae, which is partially dependent on autolysin 373
LytA 32,50,51 . Thus, by exploiting micro-invasion, the pneumococcus may carefully calibrate the host 374 innate immune/ inflammatory response to promote survival through transmission. 375 376 A range of pneumococcal PAMPs including pneumolysin, may trigger this epithelial sensing 377 process 18,52 . We found pneumolysin to be a prominent inducer of epithelial surface molecule 378 upregulation, cytokine production and transcriptomic inflammatory response in vitro. Following 379 internalisation of the pneumococcus by neutrophils, pneumolysin has been shown to induce ROS 380 following bacterial autolysis, which leads to cellular activation 53 . We speculate that pneumolysin 381 released intracellularly may signal directly in epithelial cells or through host cell pore-formation 382 leading to entry of other PAMPs. Mediated by autolysin, the pneumococcus undergoes autolysis 383 during stationery growth phase, resulting in additional PAMPs' release including bacterial DNA 53 . In 384 mice, pneumococcal DNA triggers inflammation through a DAI/STING/TBK1/IRF3 cascade 45,54 , a 385 response that may contribute to pneumococcal clearance. In our in vitro transcriptomic analyses, we 386 detected enriched activation of IRF3/IFR7 in dPly-TIGR4. We suggest that in the context of micro-387 invasion, pneumococcal DNA may also act as a trigger of epithelial sensing, inducing inflammation 54 . In conclusion, our data implicates the novel finding of micro-invasion during pneumococcal 397 colonisation of otherwise healthy humans, promoting epithelial-derived innate immunity/ 398 inflammation and ultimately clearance. The pathways critical for onward pneumococcal transmission 399 remain to be determined in humans but based on murine models, we propose that this epithelial 400 response may also facilitate transmission. The balance between innate immunity/ inflammation-401 driven transmission and clearance may be further modulated by the frequency of carriage events, 402 pneumococcal strain co-colonisation, viral co-infections and other environmental pressures 1,22,48 . 403
Our approach combining in vitro with in vivo human systems offers a potentially tractable way to 404 further interrogate these processes. vegetone broth as previously described 60 . Individuals naturally colonised with S. pneumoniae or in 630 regular contact with at-risk individuals were excluded (except for EM images in Supplementary 631 Figure 1b ). Blood and mucosal T cell and antibody immunity were not systematically measured in 632 this cohort but previous studies of volunteers from this population have demonstrated background T 633 cell and antibody-mediated anti-pneumococcal immunity, but a relationship between pre-challenge 634 immunity and the development of carriage in the model has not been established 21, 23 . To exclude 635 the influence of viral-coinfection, EHPC model volunteers who had coryzal or flu-like symptoms prior 636 to challenge were excluded. Volunteers were screened for the presence of 20 common respiratory 637 viruses before inoculation. 1/13 asymptomatic volunteers (volunteer 1) was positive for enterovirus. 638
Nasal washes and mucosal cells (curette biopsy) from the inferior turbinate were obtained by PBS 639 syringe and curettage using a plastic Rhino-probe™ (Arlington Scientific), in this order of collection 640 respectively, before pneumococcal inoculation. Sampling was then repeated on days 2, 6, 9, and 14 641
used as a control. Cells were washed and treated with gentamicin and lysed with saponin as 686 described above. 687 688
Confocal Microscopy 689
For the in vivo analysis, mucosal cells derived by curettage from the EHPC model were placed 690 directly into 4% PFA for 1 hour. Cells were cytospun onto microscope slides and allowed to air dry. 691
For the in vitro analysis, epithelial cell lines on transwell membranes were fixed in either 4% PFA 692 Fixable Zombie Blue UV Cell Stain (Biolegend) for 30 minutes before rinsing in 1ml base media and 740 centrifuging at 300g for 5 minutes at 4 o C. Cells were fixed in 600µl of 4% PFA and acquired on an 741 LSR II Flow Cytometer (BD Biosciences). Compensation was run and applied for each experimental 742 replicate and voltages consistent throughout. Isotype controls (BD Biosciences), FL-1 and single 743 stains were also run for each experiment. Samples were acquired until 300,000 events had been 744 collected. Analyses were performed using FlowJo LLC version 10 software. All data processing and analysis was conducted in R, language and environment for statistical 767 computing (https://www.R-project.org). Paired end reads were mapped to the Ensembl human 768 transcriptome reference sequence (homo sapiens GRCh38). Mapping and generation of read counts 769 per transcript were performed using Kallisto 62 , based on pseudoalignment. R/Bioconductor package 770
Tximport was used to import the mapped counts data and summarise the transcripts-level data into 771 gene level data 63 . DESeq2 and SARTools packages 64 , were used for differential gene expression 772 analysis, using a false discovery rate (FDR) <0.05, following normalisation with a negative binomial 773 generalised linear model. In addition, transcript abundance for protein coding genes was expressed 774 carriage negative and carriage positive, on each day of sampling, was analysed by 1-way ANOVA 847 (a -parametric, b -non-parametric). P = 0.84 CD54 MFI; p = 0.98 CD54 %; p = 0.09 CD107a MFI; 848 p = 0.10 CD107a %. 849 Pneumococcal adhesion and micro-colony formation on the epithelial surface may lead to micro-929 invasion; internalisation of the bacteria and/ or transmigration across the epithelial barrier (micro-930 invasion). The epithelial-derived response is dependent on the subsequent pattern of interactions. 931
Micro-invasion amplifies epithelial sensing and inflammation/ innate immunity, which we postulate 932 leads to immune cell engagement. This process of epithelial sensing inflammation/ innate immunity 933 may enhance both clearance and transmission. Co-association with junctional proteins may facilitate 934 migration across the barrier. 935 
